Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?

Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?

Abstract Standard pharmacological therapy in Takotsubo syndrome (TTS) is still debated and there is a lack of prospective data. In their recent work in BMC Cardiovascular Disorders Abanador-Kamper et al. found that stroke in TTS has an event rate of 2.8% after 30 days and 4.2% after 12 months and th...

Full description

Bibliographic Details
Main Authors: Francesco Santoro, Thomas Stiermaier, Francesca Guastafierro, Nicola Tarantino, Ingo Eitel, Natale Daniele Brunetti
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Oral anticoagulation
Left ventricular thrombi
Stroke
Prognosis
Follow-up
Broken heart syndrome
Online Access:http://link.springer.com/article/10.1186/s12872-018-0930-1

Internet

http://link.springer.com/article/10.1186/s12872-018-0930-1

Similar Items